...
首页> 外文期刊>Bioorganic and medicinal chemistry >Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
【24h】

Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.

机译:2-(噻吩基-2-基或-3-基)-4-呋喃基-6-芳基吡啶衍生物的合成及其拓扑异构酶I和II的抑制活性,细胞毒性和结构活性关系的评估。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A series of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives were designed, synthesized, and evaluated for their topoisomerase I and II inhibition and cytotoxic activity against several human cancer cell lines. Compounds 10-19 showed moderate topoisomerase I and II inhibitory activity and 20-29 showed significant topoisomerase II inhibitory activity. Structure-activity relationship study revealed that 4-(5-chlorofuran-2-yl)-2-(thiophen-3-yl) moiety has an important role in displaying topoisomerase II inhibition.
机译:设计,合成了一系列2-(噻吩-2-基或-3-基)-4-呋喃基-6-芳基吡啶衍生物,并对其拓扑异构酶I和II的抑制作用以及对几种人类癌细胞系的细胞毒活性进行了评估。化合物10-19显示出中等的拓扑异构酶I和II抑制活性,而化合物20-29显示出显着的拓扑异构酶II抑制活性。结构-活性关系研究表明4-(5-氯呋喃-2-基)-2-(噻吩-3-基)部分在显示拓扑异构酶II抑制作用中具有重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号